Related Experiment Videos
Platelet aggregability and occurrence of restenosis following coronary angioplasty
P K Goel1, M Shahi, A K Agarwal
1Department of Cardiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Insights
High basal platelet aggregability may predict restenosis after percutaneous coronary angioplasty (PTCA). This finding suggests platelet function testing could identify patients at risk for restenosis following coronary procedures.
Area of Science:
- Cardiology
- Hematology
- Vascular Biology
Background:
- Restenosis after percutaneous coronary angioplasty (PTCA) affects nearly a third of patients.
- Platelets play a key role in restenosis, but no platelet function parameter predicts its occurrence.
- Predicting restenosis risk in individual patients remains a challenge.
Purpose of the Study:
- To prospectively assess platelet activation as a predictor of restenosis after PTCA.
- To investigate the relationship between basal platelet aggregability and restenosis development.
Main Methods:
- Prospective study of 22 stable angina patients undergoing successful PTCA.
- Platelet activation measured via adenosine di-phosphate (ADP)-induced aggregability pre-PTCA and at 1, 7, and 28 days post-PTCA.
- Restenosis assessed by angiographic follow-up.
Main Results:
- No significant change in overall platelet aggregability over time post-PTCA.
- Patients who developed restenosis showed significantly higher basal platelet aggregability (38.7%) compared to those without restenosis (25.0%).
- A p-value of 0.0128 indicated statistical significance.
Conclusions:
- Elevated basal platelet aggregability is a significant predictor of restenosis post-PTCA.
- Platelet function testing, specifically basal aggregability, may serve as a valuable marker for identifying patients at risk of restenosis.
Abstract:
Restenosis following percutaneous coronary angioplasty (PTCA) is a complex medical problem occurring in nearly a third of the patients undergoing PTCA with no single definite predictor demonstrated in an individual patient. Platelets are known to play an important role in the pathogenesis of the restenotic process. However, no known parameter of platelet function or activity has been studied as a risk factor predicting the occurrence of restenosis. We prospectively assessed platelet activation in twenty two consecutive patients with stable angina who underwent a successful PTCA for single vessel coronary artery disease. Platelet activation levels were measured using aggregability curves derived from unclotted blood samples on a platelet aggregometer using varying concentrations of adenosine di-phosphate (ADP) in the following time sequence: (1) Basal i.e. pre-PTCA, (2) post-PTCA day 1, (3) post-PTCA day 7, and (4) post-PTCA day 28. Occurrence of restenosis was studied using angiographic follow-up in all patients. At follow-up, seven of the twenty two patients studied developed restenosis. There was no significant difference or any specific trend noted over time in the levels of platelet aggregability in the study group as a whole (basal: 30.0 +/- 15.4%, post-PTCA day 1: 32.5 +/- 16.1%, post-PTCA day 7: 34.6 +/- 15.4% and post-PTCA day 28: 32.6 +/- 16.1%). However, when the patients were subgrouped into those with and without restenosis, the patients with restenosis had a significantly higher basal platelet aggregability (38.7 +/- 16.3%) versus those who did not develop restenosis (25.0 +/- 12.1%), p = 0.0128. We conclude that patients developing restenosis after PTCA have a significantly higher basal platelet aggregability and this could be used as a marker for its occurrence in an individual patient.